Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? (2019)
- Authors:
- Autor USP: ABDALA, EDSON - FM
- Unidade: FM
- DOI: 10.1111/myc.12901
- Subjects: FÁRMACOS IMUNOSSUPRESSORES; FUSARIUM; PREVENÇÃO DE DOENÇAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NUCCI, Marcio et al. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?. Mycoses, v. 62, n. 5, p. 413-417, 2019Tradução . . Disponível em: https://doi.org/10.1111/myc.12901. Acesso em: 23 jan. 2026. -
APA
Nucci, M., Shoham, S., Abdala, E., Hamerschlak, N., Rico, J. C., Forghieri, F., et al. (2019). Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? Mycoses, 62( 5), 413-417. doi:10.1111/myc.12901 -
NLM
Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouer SA, Cappellano P, Solza C, Gonzaga Y. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? [Internet]. Mycoses. 2019 ; 62( 5): 413-417.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1111/myc.12901 -
Vancouver
Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouer SA, Cappellano P, Solza C, Gonzaga Y. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? [Internet]. Mycoses. 2019 ; 62( 5): 413-417.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1111/myc.12901 - Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement
- Role of lock therapy for long-term catheter-related infections by multidrug-resistant bacteria
- Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America
- Antifungal and Antibacterial Activity of Terpenes for Improvement of Indoor Air Quality
- Contribuição científica para o manejo das infecções em transplantes de órgãos sólidos
- Infeccoes em 35 pacientes submetidos a transplante de figado: incidencia, agentes etiologicos e evolucao
- Infecção por vírus Monkeypox: avaliação do doador e do candidato ao transplante de órgãos sólidos
- Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors
- Avaliação da translocação bacteriana no transplante de fígado realizado pelos métodos convencional e "piggyback"
- Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
Informações sobre o DOI: 10.1111/myc.12901 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
